Vet drugmaker Chanelle Group putting €70M into Ireland plant

Ireland-based Chanelle Group, a maker of veterinary generic drugs, has big plans for its manufacturing facility in Loughrea County in Galway. It will invest €70 million ($78 million) to double capacity and will add 175 jobs when it is complete, bringing the company's employment to more than 550 in West Ireland. Construction on the 30,000-square-foot expansion is slated to begin in March, the company said in an announcement. Michael Burke, founder and managing director of Chanelle Group, said the company will also be expanding into new markets, including the U.S. and Central and South America. Release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.